Table of Contents
Overview
Definition of Biotechnology
Biotechnology is the application of biological processes, organisms, and systems to create products and technologies that enhance human health and the environment. This field, known as biotech, has roots in early civilization, with practices such as the domestication of plants and animals and the discovery of fermentation.[2.1] Over the past century, biotechnology has advanced significantly, particularly through genetic engineering, which involves modifying DNA to change the traits or functions of living organisms.[3.1] Modern biotechnology encompasses a wide range of applications, including the development of new medical treatments, genetically modified crops, sustainable biofuels, and environmental solutions.[4.1] These innovations highlight biotechnology's essential role in enhancing agricultural productivity, improving human health, and addressing environmental challenges.[4.1] The field primarily relies on genetic engineering, which manipulates DNA to alter the traits of various life forms, including microorganisms, plants, and animals, conducted in laboratory settings rather than through traditional selective breeding.[3.1] Biotechnology's diverse applications contribute to advancements in health care, agricultural productivity, and sustainable industrial practices.[5.1] Furthermore, biotechnology addresses contemporary challenges by developing new medical treatments, enhancing food security through genetically modified crops, and creating sustainable biofuels.[4.1] It represents a significant intersection of biology and technology, with the potential to improve the quality of life and promote _environmental sustainability.[4.1]Key Principles and Techniques
Biotechnology integrates a variety of principles and techniques that utilize biological systems and organisms to create innovative products and technologies. A key component of biotechnology is genetic engineering, which enables precise modifications to an organism's DNA. This has been instrumental in developing genetically modified organisms (GMOs) with enhanced traits, such as increased pest and disease resistance, improved yield, and better environmental adaptability.[14.1] Advancements in genetic engineering, including viral vectors, nanoparticles, and electroporation, have improved the delivery of genetic material into cells, facilitating successful genetic modifications.[12.1] Sequencing technologies further enhance genetic engineering by identifying genes linked to desirable traits, benefiting both agriculture and medicine.[15.1] Beyond genetic engineering, biotechnology optimizes drug development processes through methodologies like advanced analytics, artificial intelligence (AI), and machine learning. These tools provide real-time insights for decision-making throughout research and development (R&D), supporting a modular architecture that enhances drug discovery efficiency, leading to shorter timelines and higher success rates.[8.1][11.1] Biotechnology has revolutionized drug development, driving the creation of innovative therapeutics by integrating cutting-edge science and technology. This approach addresses complex medical challenges and improves the discovery, design, and production of therapeutic agents.[9.1] Unlike traditional pharmaceutical methods, biopharmaceuticals utilize a diverse array of over a hundred ingredients, including complex items like DNA and cell lines.[6.1] Advances in biomanufacturing have shifted production methods from batch to real-time sampling, enhancing environmental monitoring through batch-specific approaches.[6.1] Continuous data collection and analysis are crucial for understanding complex biological interactions and refining manufacturing processes, underscoring the importance of sophisticated data management systems in biopharmaceutical development.[6.1]History
Early Applications of Biotechnology
The history of biotechnology can be traced back to ancient civilizations, where early applications laid the groundwork for modern advancements. One of the earliest forms of biotechnology was fermentation, utilized by ancient societies to produce bread, beer, and wine, demonstrating an early manipulation of biological processes to enhance food production and improve quality of life.[58.1] In approximately 6000 BC, the Sumerians and Babylonians exemplified this practice by mastering the fermentation of yeast to brew beer. This technique was based on observation and tradition rather than scientific understanding, showcasing an early form of biotechnological application.[59.1] Additionally, around 4000 BC, the Egyptians employed biotechnology in their mummification processes, which, while primarily a religious and cultural practice aimed at preserving bodies for the afterlife, indicated a basic understanding of biological preservation techniques.[57.1] These ancient practices not only highlight the ingenuity of early civilizations but also set the stage for the evolution of biotechnology into a cornerstone of modern science and industry, paving the way for significant advancements such as genetic engineering and CRISPR technology.[56.1]Evolution of Biotechnology in the 20th Century
The 20th century marked a significant evolution in biotechnology, characterized by groundbreaking discoveries and technological advancements that reshaped the field. The term "biotechnology" was coined by Karl Erkey in 1919, establishing a foundation for future developments in the discipline.[66.1] Early in the century, pivotal contributions were made by scientists such as Gregor Mendel, whose Laws of Inheritance laid the groundwork for genetics, and Louis Pasteur, who pioneered vaccination and made substantial contributions to microbiology.[66.1] A transformative moment occurred in 1953 when James Watson and Francis Crick unveiled the double-helix model of DNA, fundamentally altering our understanding of genetic material.[53.1] This discovery not only advanced molecular biology but also paved the way for genetic engineering, allowing scientists to manipulate genes with unprecedented precision.[55.1] The subsequent development of recombinant DNA technology in the 1970s revolutionized genetic engineering, enabling the production of therapeutic proteins and other drugs through genetic manipulation.[55.1] The practical applications of these advancements became evident in the early 1980s when the first genetically engineered product, human insulin produced in bacteria, was used in medical practice.[54.1] This milestone was followed by the FDA's approval of recombinant insulin for diabetes treatment in 1982, marking a significant achievement in biotechnology.[54.1] The 1980s also saw the National Academy of Sciences conclude that transferring genes between species posed no serious environmental hazards, further legitimizing biotechnological innovations.[54.1] Throughout the century, the field continued to expand, with notable achievements such as Craig Venter's sequencing of the human genome, which advanced our understanding of genetics and opened new avenues for research and application.[66.1] The ethical implications of these advancements, particularly concerning genetically modified organisms (GMOs) and cloning, emerged as critical considerations in the modern era of biotechnology.[68.1] As biotechnology progressed, it became increasingly intertwined with ethical debates, necessitating careful consideration of the implications of these powerful technologies.Recent Advancements
CRISPR and Genetic Engineering
Recent advancements in biotechnology have prominently featured CRISPR technology, particularly in the realm of genetic engineering. CRISPR-Cas9, a revolutionary gene-editing tool, has been utilized across various human cell lines, including human embryonic kidney cells and induced pluripotent stem cells, demonstrating its versatility and effectiveness in genome editing.[102.1] This technology is distinguished from earlier gene-editing methods such as ZFNs and TALENs due to its derivation from a natural mechanism, allowing for precise targeting of specific DNA sequences.[102.1] The application of CRISPR in combating genetic diseases has shown promising results in ongoing clinical trials. For instance, trials aimed at treating β-thalassemia and severe sickle cell disease through the transfusion of CRISPR/Cas9 edited human hematopoietic stem cells have been initiated, showcasing the potential of CRISPR to address the root causes of genetic disorders.[105.1] Furthermore, CRISPR's capabilities extend to cancer treatment, where it has been employed to target genes associated with various cancers, thereby facilitating the identification of new drug targets and biomarkers.[104.1] Despite its potential, the translation of CRISPR technology into clinical applications faces significant challenges. One of the foremost concerns is the risk of off-target effects, which can lead to unintended genetic alterations and potential safety issues, including cell death and chromosomal disorganization.[107.1] Researchers are actively working to enhance the precision of CRISPR by developing more accurate Cas9 variants and optimizing guide RNA designs.[107.1] Additionally, alternative systems that do not introduce double-strand breaks, such as base editing and prime editing, are being explored to mitigate these risks while expanding the therapeutic potential of gene editing.[107.1]Biotechnology in Healthcare
Recent advancements in biotechnology have significantly transformed healthcare, particularly through the development of personalized medicine and innovative treatment strategies. In 2023, the biotech industry has made notable progress in various areas, including treatments for Alzheimer’s disease, cancer therapies, and obesity management, reflecting a commitment to addressing complex health challenges.[89.1] One of the key advancements in biotechnology is the integration of computational biology and multiomics data, which enhances precision medicine in cancer treatment. This approach aims to refine and individualize therapeutic strategies by combining various biological data types, thereby improving patient outcomes.[93.1] The evolution of personalized medicine is further supported by advancements in genomics and proteomics, which provide complementary insights into disease mechanisms. By integrating genomic data with protein expression profiles, researchers can identify therapeutic targets and biomarkers, facilitating early diagnosis and monitoring of disease progression.[95.1] The application of artificial intelligence (AI) in biotechnology has also revolutionized healthcare delivery. AI technologies are being utilized for drug discovery, treatment optimization, and extensive data analysis, significantly enhancing the efficiency of medical processes.[98.1] However, the integration of AI raises ethical considerations, particularly concerning data privacy and security. Healthcare organizations must proactively address these challenges to build trust with patients and ensure responsible use of AI technologies.[99.1]In this section:
Applications Of Biotechnology
Agricultural Innovations
Transgenic crops represent a significant advancement in agricultural biotechnology, particularly in enhancing sustainability and environmental protection. The adoption of genetically modified (GM) crops has been shown to improve the sustainability of agricultural practices, allowing for a reduction in reliance on chemical controls for plant diseases through genetic solutions.[133.1] However, concerns regarding the potential environmental impacts of these crops persist, particularly in megadiverse regions that are centers of origin for various crop species, which may be vulnerable to biodiversity loss.[134.1] To address these environmental concerns, regulatory measures are in place before transgenic plants can be cultivated outside laboratory settings. Approval from the Animal and Plant Health Inspection Service (APHIS) of the United States Department of Agriculture (USDA) is required, ensuring that the introduction of GM crops adheres to guidelines aimed at minimizing ecological risks.[136.1] These risks include potential effects on biodiversity, gene flow, and the evolution of resistance in pests and weeds, which are critical factors in assessing the long-term sustainability of transgenic crops.[135.1] Agricultural biotechnology is essential for developing climate-resilient crops, particularly as the global population increases and agricultural land diminishes, which poses significant challenges to food security.[151.1] This field employs advanced breeding techniques and genetic resources to create crop varieties capable of withstanding abiotic stresses, such as drought and salinity.[149.1] Notably, gene editing technologies, including CRISPR/Cas-9, have demonstrated potential in enhancing traits like drought and salt tolerance by targeting specific genes, thereby contributing to the development of resilient crop varieties.[149.1] Through these innovative approaches, agricultural biotechnology aims to ensure sustainable yield production and address the adverse effects of climate change on agriculture.[151.1] Furthermore, agricultural biotechnology is recognized as a key tool in achieving societal goals such as poverty reduction and improved global food security while minimizing environmental impacts.[150.1] The integration of these biotechnological innovations into agricultural practices is essential for developing sustainable solutions that can meet the demands of a growing population while protecting the planet's ecosystems.Industrial Applications
Biotechnology has a significant impact on various industrial applications, leveraging cellular and molecular processes to develop products and technologies that enhance human life and address environmental challenges. One of the primary areas of industrial biotechnology is the creation of new enzymes and their immobilization for industrial use, which facilitates more efficient manufacturing processes across multiple sectors.[127.1] Additionally, biotechnology plays a crucial role in pollution control through bioremediation, which utilizes biological organisms to clean up contaminated environments.[129.1] This application is particularly important in addressing environmental issues and promoting sustainability. Biotechnology encompasses a diverse array of applications across multiple fields, significantly impacting areas such as medicine, agriculture, and environmental management. In the medical field, biotechnology is pivotal in the production of diagnostics and therapeutics, including monoclonal antibodies, stem cells, and gene therapy, which contribute to advancements in human health.[129.1] Agricultural biotechnology enhances crop production and food security, while also addressing environmental concerns through pollution control methods like bioremediation.[130.1] Furthermore, industrial biotechnology plays a crucial role in the development of biomaterials, which are increasingly utilized in various sectors, including food processing and packaging, due to their sustainable and biodegradable properties.[129.1] Overall, the applications of biotechnology are extensive and vital for improving human life and addressing critical global challenges.[130.1]In this section:
Agricultural BiotechnologyEnvironmental ProtectionChemical ControlsPlant DiseasesBiodiversity Loss
Environmental Impact
Bioremediation Techniques
Bioremediation techniques represent a cutting-edge and ecologically sustainable approach to addressing environmental pollution, particularly through the use of biological microorganisms to decompose and neutralize pollutants. This method plays a crucial role in removing environmental toxins, thereby restoring ecosystems to their natural state and preventing further contamination.[186.1] A notable case study illustrating the effectiveness of bioremediation is the Exxon Valdez oil spill in 1989, where bioremediation techniques were employed to introduce oil-degrading bacteria, showcasing an eco-friendly approach to industrial accidents.[185.1] The environmental impacts of the Exxon Valdez spill were significant, leading to its frequent comparison with the BP Deepwater Horizon spill in 2010, despite the differences in the nature of the spills and the environments affected.[187.1] The application of bioremediation extends beyond oil spills; it is increasingly recognized as a viable solution for managing agro-industrial waste. This innovative approach not only reduces environmental pollution but also enables the production of value-added products, aligning with the principles of a circular bioeconomy.[188.1] By integrating biorefinery concepts with bioremediation, microbial pathways can be harnessed to achieve "zero waste" outcomes, producing marketable products such as biopolymers, biofuels, and biochemicals.[188.1] As water pollution continues to pose a critical threat, bioremediation stands out as a sustainable solution with the potential to restore polluted water ecosystems. Its eco-friendly nature, cost-effectiveness, and adaptability make it a valuable tool in the broader effort to address the complex challenges of water pollution.[195.1] However, the deployment of biotechnological innovations, including bioremediation, must be approached cautiously to avoid unintended ecological consequences that could disrupt ecosystems and create new problems.[196.1] Recent advancements in biotechnology, particularly in metabolic engineering and synthetic biology, have further enhanced the efficiency of microbial cell factories in breaking down pollutants and producing renewable chemicals.[197.1] These developments underscore the practical impact of bioremediation techniques across various sectors, including energy, materials, and chemicals, transforming waste streams into valuable resources.[197.1]Sustainable Practices in Biotechnology
Sustainable practices in biotechnology play a crucial role in addressing environmental challenges and promoting ecological balance. One significant benefit of environmental biotechnology is its ability to create a safer and cleaner environment, which is essential for sustainable development. This field focuses on adapting organisms to environmental changes while maintaining cleanliness and safety for future use.[171.1] Agricultural biotechnology, in particular, has been identified as a key player in mitigating climate change by reducing greenhouse gas emissions. For example, the development of cover crops through biotechnology can lead to sustainable biofuels, thereby decreasing reliance on fossil fuels.[172.1] Furthermore, biotechnology contributes to the conservation and sustainability of the environment by integrating biological and technological concepts to benefit humanity.[173.1] The positive impacts of biotechnology extend to reducing environmental pollution, enhancing food production, and producing sustainable chemicals and energy. This includes the advancement of genetically modified crops designed for sustainable food production and the utilization of seawater bioprocesses for fuel and chemical production.[174.1] Additionally, biotechnology aids agriculture in adapting to climate change by developing crops that are resilient to drought, heat, and salinity, which helps preserve ecosystems by reducing the need for land conversion.[175.1] However, the implementation of biotechnology must be approached with caution to avoid unintended ecological consequences. Concerns have been raised regarding the potential loss of biodiversity and the development of resistant pests due to the widespread use of genetically modified organisms (GMOs).[179.1] It is essential to evaluate the ecological consequences of biomass production systems and the relationships between genetic diversity in crop systems and biodiversity indicators, such as arthropod abundance.[176.1] To balance the benefits of biotechnology with ecological sustainability, expanding genetic diversity in crops is vital for climate resilience. This diversification can help mitigate the risks associated with monoculture practices and enhance the adaptability of agricultural systems to changing environmental conditions.[177.1]Ethical Considerations
Genetic Privacy Issues
Genetic privacy issues represent significant ethical concerns within the field of biotechnology. The manipulation of genetic codes, cloning, and gene therapy raises critical questions regarding privacy and intellectual property rights. These advancements can lead to potential misuse of genetic information, which may have profound implications for individuals and society as a whole. Ethical issues in biotechnology are categorized into various domains, including socio-economic, cultural, legal, environmental, and religious concerns, all of which intersect with the notion of genetic privacy.[213.1] As biotechnology progresses, the ethical implications surrounding gene therapy and genetic manipulation necessitate careful consideration to balance the potential for scientific advancement with the preservation of moral standards.[217.1] The public's perspective on these moral and ethical considerations is crucial, especially regarding the potential misuse of genetic information and the implications for individual privacy.[217.1] The ethical assessment of new technologies, particularly in biotechnology, necessitates a distinct approach due to the profound impact these innovations can have on individuals and society.[216.1] This is particularly true in the realm of genetic manipulation, which raises significant ethical concerns that extend beyond mere scientific considerations. The morality of genetic manipulation involves philosophical questions about the very fabric of life, as it can lead to a society where individuals are valued primarily for their genetic traits, thereby undermining the Kantian principle of respecting the inherent worth of every person.[218.1] Moreover, the potential for biotechnology to manipulate human nature highlights the limitations of a rights-based approach to ethics, emphasizing the need for careful ethical reflection on the implications of these advancements.[216.1] As such, the discourse surrounding genetic privacy is intricately linked to these ethical dilemmas, underscoring the importance of addressing the moral implications of genetic technologies.[218.1] In the context of germline editing, which involves changes that can be passed down to future generations, the ethical concerns are amplified. Many countries have discouraged or banned research on germline editing due to these ethical and safety concerns, highlighting the need for robust regulatory frameworks to protect genetic privacy.[221.1] The potential for inequitable access to genetic technologies also raises questions about justice and equity, as there is a fear that such advancements may only be available to the wealthy, exacerbating existing disparities in healthcare.[221.1] Ultimately, addressing genetic privacy issues in biotechnology requires ongoing global engagement and discussion, as well as the establishment of international guidelines and ethical frameworks to ensure that advancements in this field benefit society as a whole while respecting individual rights.[212.1]Debates on Genetically Modified Organisms (GMOs)
The debates on genetically modified organisms (GMOs) are complex, involving ecological, ethical, and regulatory considerations. Central to these discussions is the evaluation of biotechnological interventions in agriculture, which requires a comprehensive understanding of their ecological impacts. While GMOs are acknowledged for their potential to boost crop productivity and resource efficiency, concerns about their long-term effects on biodiversity and ecosystem functioning persist, remaining uncertain.[224.1] Biotechnology offers innovative solutions to environmental challenges, such as pollution remediation and climate change mitigation. However, these interventions, including pest-resistant crops, may inadvertently affect non-target species, presenting ethical and environmental trade-offs that need careful consideration.[225.1] Addressing these complexities demands robust risk assessment frameworks, public dialogue, and adaptive governance to ensure sustainable and environmentally responsible biotechnological practices.[225.1] Regulatory frameworks are crucial in shaping biotechnology, encompassing laws and guidelines to ensure safety, efficacy, and ethical compliance. Regulatory bodies must develop adaptive frameworks that effectively respond to novel biotechnologies while considering public health and safety.[249.1] The interplay of compliance and enforcement mechanisms is vital for addressing regulatory issues in biotechnology, thereby fostering public confidence in biotechnological advancements.[249.1] The regulatory approval process involves structured steps to assess safety and compliance before products enter the market, emphasizing the importance of clear communication of these policies to both the scientific community and the public.[249.1]Future Trends
Integration of AI and Biotechnology
The integration of artificial intelligence (AI) into biotechnology is poised to significantly enhance various aspects of drug discovery and development. AI is transforming the drug discovery process by improving target identification, optimizing lead compounds, and enhancing predictive modeling for safety and efficacy. For instance, AI-driven models can analyze vast datasets to predict molecular interactions and optimize drug candidates with unprecedented speed, as demonstrated in a study that identified new therapeutic targets for Alzheimer’s disease through network-based approaches analyzing protein-protein interactions and gene co-expression data.[287.1] Moreover, AI-based methodologies have shown the potential to streamline the drug discovery process by combining predictive power with human expertise, thereby accelerating the development of new medications.[288.1] Recent advancements, such as the use of data augmentation and explainable AI, further illustrate the promising strategies that can overcome existing challenges in drug discovery.[288.1] Despite the advantages, the integration of AI in drug discovery also faces limitations, particularly in the context of cancer treatment. High costs, long timelines, and low success rates characterize the traditional drug development landscape, with approximately 90% of candidates failing to reach the market.[289.1] However, AI can mitigate these challenges by improving target identification and predicting druggability, thereby enhancing the overall drug discovery process. For example, PaccMann, an AI-driven framework, predicts cancer cell sensitivity to compounds by integrating molecular structures, gene expression profiles, and protein interaction data.[289.1] The success of AI-discovered drugs in clinical trials further underscores the potential of AI in biotechnology. Analysis of clinical pipelines for AI-native biotech companies reveals that AI-discovered molecules exhibit an 80–90% success rate in Phase I trials, significantly higher than historical industry averages.[290.1] This early evidence suggests a promising future for AI-driven drug discovery, highlighting its capacity to revolutionize the biotechnology landscape. The integration of artificial intelligence (AI) in biotechnology, particularly in drug discovery, has become increasingly significant due to its ability to enhance the prediction of drug-target interactions. Machine learning (ML) and deep learning models are employed to predict binding affinities using both ligand-based and target-based approaches, which can lead to substantial savings in time and costs associated with drug discovery efforts.[292.1] Detecting drug-drug interactions (DDIs) is a crucial aspect of drug development and administration, and the ML approach has emerged as a reliable alternative to traditional experimental methods, garnering considerable attention from both academic and industrial sectors.[293.1] Furthermore, a systematic review has highlighted the applications of explainable AI in DDI prediction, emphasizing its importance in improving the transparency and reliability of predictions, which is essential for fostering confidence in AI-driven methodologies.[294.1]Predictions for Biotechnology by 2025
As the biotechnology sector progresses, several key trends are anticipated to shape the landscape by 2025. Among these, the integration of artificial intelligence (AI) in drug discovery is particularly noteworthy. AI-driven methodologies are expected to enhance the efficiency and accuracy of identifying potential therapeutic candidates, thereby accelerating the timeline for bringing new drugs to market.[255.1] Additionally, advancements in gene editing and cell therapies are gaining attention, as they represent a wide range of approaches aimed at treating diseases at the cellular and genetic levels. Researchers are focusing on innovative solutions, such as genetically engineering pig organs to be compatible with human immune systems, which could revolutionize transplantation and treatment options.[257.1] Overall, the convergence of AI, gene editing, and cell therapies is set to drive significant advancements in biotechnology in the coming years. By 2025, the biotechnology sector is expected to witness significant advancements, particularly in the realms of cell and gene therapies. These therapies encompass a variety of approaches aimed at treating diseases at the cellular and genetic levels, with a focus on delivering genetic material to patients to replace or correct faulty DNA.[257.1] Notably, researchers are exploring the genetic engineering of pig organs, such as hearts, lungs, and kidneys, to ensure their compatibility with the human immune system, which could pave the way for xenotransplantation.[257.1] As the industry progresses, it is crucial to ensure that these innovations are carefully regulated to maximize benefits while minimizing risks.[258.1] The year 2023 has already demonstrated steady progress and breakthroughs in the biotech field, particularly in treatments for Alzheimer’s disease and cancer, highlighting the industry's commitment to addressing some of the most pressing health challenges.[261.1] Overall, the developments in biotechnology are poised to transform healthcare and improve patient outcomes significantly. The biotechnology landscape in 2024 is characterized by rapid advancements and ethical considerations, with a regulatory environment that is currently in flux. This evolving regulatory landscape is crucial as it influences innovation across various sectors, including agriculture and medicine. Companies that proactively navigate these shifts will not only ensure compliance with emerging regulations but also position themselves as leaders in shaping the future of biotechnology.[264.1] The interplay between biotech innovations and legal oversight underscores the importance of robust regulations, which are essential for safeguarding public health and ecological integrity while fostering innovation.[262.1] As society increasingly relies on genetic technologies, the significance of these regulations cannot be overstated, as they play a vital role in the development of new therapies. The biotechnology sector has experienced significant advancements in 2023, marked by notable breakthroughs in various fields such as Alzheimer’s disease treatments, cancer therapy, and obesity management. These developments underscore the industry's commitment to addressing some of the most pressing health challenges faced globally.[261.1] As we look ahead, the global biotechnology market, currently valued at approximately $752.8 billion, is poised for continued growth, driven by innovations that are transforming health, medicine, and agriculture.[260.1] The ongoing progress in biotechnology not only reflects the sector's critical role in enhancing healthcare solutions but also highlights its potential to shape the future of medical research and application.[261.1]In this section:
References
[2] What is Biotechnology? Definition, Types and Applications - TechTarget — Biotechnology is the use of biology to develop new products, methods and organisms intended to improve human health and society. Biotechnology, often referred to as biotech, has existed since the beginning of civilization with the domestication of plants, animals and the discovery of fermentation. However, the discipline has evolved significantly over the last century in ways that manipulate the genetic structures and biomolecular processes of living organisms. Modern applications of biotechnology work most often through genetic engineering, which is also known as recombinant DNA technology. These modified and new organisms may be beneficial to humans, such as crops with higher yields or increased resistance to drought.
[3] Biotechnology & Genetic Engineering: An Overview - Sciencing — Biotechnology & Genetic Engineering: An Overview | Sciencing Biotechnology relies on the field of genetic engineering, which modifies DNA to alter the function or other traits of living organisms. Genetic engineering is possible in all living cells; this includes micro-organisms such as bacteria and individual cells of multicellular organisms, such as plants and animals. Modern genetic engineering happens in a laboratory instead of by selective breeding, since genes are copied and moved from one piece of DNA to another, or from one organism's cell to another organism's DNA. Genetic engineering is the foundation of biotechnology, since the biotechnology industry is, in a general sense, a vast field that involves making use of other living species for humans' needs. https://www.sciencing.com/biotechnology-genetic-engineering-an-overview-13718445/
[4] What is Biotechnology? Definition, Types, Applications, and Future — What is Biotechnology? What is Biotechnology Biotechnology’s applications range from developing new medical treatments and genetically modified crops to creating sustainable biofuels and environmental solutions. Biotechnology is essentially the use of biological processes and organisms to develop products and technologies that improve the quality of human life and the health of the planet. Each type of biotechnology plays a unique role in advancing our understanding and application of biological processes, contributing to improvements in health, agriculture, industry, and environmental sustainability. Biotechnology’s applications demonstrate its significant role in advancing sustainable practices, improving human health, enhancing agricultural productivity, and addressing environmental issues. What is Biotechnology Used For? These efforts in biotechnology R&D are crucial for addressing health challenges, improving agricultural practices, and developing sustainable industrial and environmental solutions. What Is Biotechnology?
[5] An Introduction to Biotechnology - PMC - PubMed Central (PMC) — In this chapter the readers will understand the potential applications of biotechnology in several fields like production of medicines; diagnostics; therapeutics like monoclonal antibodies, stem cells, and gene therapy; agricultural biotechnology; pollution control ( bioremediation); industrial and marine biotechnology; and biomaterials, as well as the ethical and safety issues associated with some of the products. This fieldof biotechnology has many applications and is involved in production of recombinant pharmaceuticals, tissue engineering products, regenerative medicines such as stem cell and gene therapy, and many more biotechnology products for better human life (Fig. 1.6).
[6] Harmonizing Progress: Bridging BioPharma, Technology, Academia, and ... — Harmonizing Progress: Bridging BioPharma, Technology, Academia, and Healthcare for Advanced Drug Manufacturing - PMC This paper proposes a quadrilateral approach to advance biopharmaceutical manufacturing by fostering collaboration among biopharma, lab informatics, healthcare systems, and academia. Advancements in bio-manufacturing entail a slew of alterations across the process spectrum: moving from batch sampling to real-time sampling6; handling a diverse range of raw materials—unlike pharma which often deals with fewer than ten ingredients, biopharmaceuticals interact with over a hundred, including complex items like DNA, cell lines, and single-use components; improving environmental monitoring, by transitioning from facility monitoring in pharma to batch-specific monitoring in biopharma; and adapting to the distinct methods of drug creation, with pharma utilizing chemical processes, while biopharmaceuticals use living cells to produce drug substances. The continuous collection and thorough analysis of diverse data sets are key, as they help unravel complex biological interactions and improve manufacturing processes, underscoring the vital role of sophisticated data management systems in biopharmaceutical development.8
[8] Boosting biopharma R&D performance with a next-generation technology ... — At the apex of the tech stack is the analytics layer, which features basic and advanced tools (such as AI and gen AI) that perform data analysis and visualization, ultimately enabling real-time insights and informed decision making throughout the R&D process. A modern pharma R&D tech stack should be built on a modular, flexible architecture that can support software-as-a-service (SaaS) platforms for core applications, cloud-based platforms for data management, and advanced DnA for differentiating insights. Once the integrated platform is in place, APIs can ensure seamless connections between core systems such as electronic laboratory notebooks and LIMSs in research or CTMSs and EDC in development, the other tech stack layers, and third parties such as clinical research organizations, ensuring seamless data flow throughout the R&D process.
[9] The Impact of Biotechnology on Drug Development — Biotechnology has profoundly transformed the landscape of drug development, introducing innovative approaches that enhance the discovery, design, and production of therapeutic agents. This article explores the impact of biotechnology on drug development , highlighting key advancements and their implications for the pharmaceutical industry.
[11] Biotech's Role in Advancing Drug Discovery — Sequence BioTech — Benefits of Biotech in Drug Discovery. Integrating biotechnology into drug discovery offers several advantages: Shortened development timelines, enabling faster delivery of treatments to patients. Increased success rates due to precise targeting and better disease modeling. Reduced costs by optimizing processes and minimizing failed trials.
[12] Genetic Engineering Advances: Agriculture, Industry, and Medicine — Published Time: 2024-10-28T16:52:19+00:00 Genetic Engineering Advances: Agriculture, Industry, and Medicine - BiologyInsights Genetic Engineering Advances: Agriculture, Industry, and Medicine Published Oct 28, 2024 Genetic engineering has evolved rapidly, reshaping agriculture, industry, and medicine. Genetic Engineering Techniques Advancements in delivery systems are crucial for introducing genetic material into cells. Viral vectors, nanoparticles, and electroporation are among the methods employed to ensure successful genetic modifications. Drought resistance is another area where genetic engineering has shown promise. Industrial Biotechnology One prominent innovation is the development of personalized medicine, which tailors treatment plans based on an individual’s genetic profile. The approval of therapies like Luxturna, which targets retinal dystrophy, highlights the progress being made in this area, providing hope for patients with previously untreatable conditions. Oct 19, 2024
[14] Why is Genetic Engineering Important and How Can It Impact Society — Through genetic engineering, scientists can modify crops to be more resistant to pests, diseases, and environmental conditions. Genetic engineering allows scientists to modify the genes of crops to enhance their yield. In conclusion, genetic engineering is important in animal husbandry because it has the potential to improve animal health and welfare, increase production efficiency, and enhance disease resistance. In agriculture, genetically modified crops can be engineered to be more resistant to pests and diseases, increasing crop yields and food production. The main applications of genetic engineering include improving crop yields and resistance to pests and diseases in agriculture, developing new treatments and therapies for genetic disorders and diseases in medicine, and enhancing the production of enzymes and other valuable substances in industry.
[15] The Significance of Genetic Engineering in Modern Science and Technology — Additionally, advancements in sequencing technologies have enabled scientists to identify and study specific genes that contribute to desired traits, further enhancing the potential of genetic engineering in agriculture. Through the use of advanced technologies and research in genetic engineering, scientists are able to harness the power of genes to develop innovative therapies and treatments for various diseases. With advancements in technology and research, genetic engineering allows scientists to manipulate the genes of organisms to achieve desired traits or outcomes. Keywords: important, biotechnology, technology, research, genetic, future, engineering, genes In conclusion, genetic engineering is an important and innovative field that holds great potential for the future of science and technology. Genetic engineering allows scientists to modify the genes of organisms to enhance their traits, improve crop yields, and develop disease-resistant strains.
[53] The Transformative Impact of DNA Double-Helix Structure Discovery on ... — The Transformative Impact of DNA Double-Helix Structure Discovery on Genetics and Biotechnology - Science Oxford Live The Transformative Impact of DNA Double-Helix Structure Discovery on Genetics and Biotechnology In April 1953, James Watson and Francis Crick introduced the double-helix model of DNA, transforming our understanding of genetic material. The discovery of the DNA double-helix structure has profound implications for science, especially in molecular biology and genetic research. The discovery of the DNA double-helix structure wasn’t without its controversies and ethical dilemmas. The controversy surrounding the DNA double-helix discovery serves as a reminder of the ethical obligations researchers must uphold to maintain integrity and trust in science. The discovery of the DNA double-helix structure has profoundly shaped our understanding of genetics and molecular biology.
[54] Historical development of genetic engineering | EBSCO — In December 1980, the first genetically engineered product was used in medical practice when a diabetic patient was injected with human insulin generated in bacteria; in 1982 the Food and Drug Administration (FDA) approved the general use of insulin produced from bacteria by recombinant DNA procedures for the treatment of people with diabetes. In 1987, a committee of the National Academy of Sciences concluded that no serious environmental hazards were posed by transferring genes between species of organisms, and this action was followed in 1988 by the US Patent and Trademark Office issuing its first patent for a genetically engineered higher animal, a mouse that was developed for use in cancer research.
[55] History of Genetic Engineering: Invention and Timeline — The first genetically engineered organisms were the product of advancements in technology that allowed scientists to manipulate and transfer genes between different organisms. Genetic engineering, the manipulation of organisms’ genes by scientists using technology and techniques, has revolutionized various industries. The discovery of recombinant DNA technology by scientists in the 1970s revolutionized genetic engineering and opened up new possibilities for manipulating and modifying genes. In the field of genetic engineering, the discovery and development of techniques for manipulating genes revolutionized the way scientists approach the modification of living organisms. The discovery and development of CRISPR-Cas9 technology has revolutionized the field of genetic engineering, allowing scientists to manipulate the genes of organisms with unprecedented precision and ease.
[56] The Comprehensive History of Biotechnology: Origins, Key Areas, and ... — With a foundation rooted in ancient practices, biotechnology has evolved dramatically to become a cornerstone of modern science and industry. From the discovery of genetic engineering to the use of CRISPR technology , biotechnology plays a pivotal role in driving advancements that are shaping the future of healthcare, agriculture, and
[57] PDF — ancient civilisations successfully used bio - technology in their everyday lives. In 4000 BC, the Egyptians began using a form of biotechnology in their intricate process of mum mi fication. 4 It was a religious and cultural practice aimed at pres - erving the body for the afterlife but showed a basic under - standing of biotechnology. The
[58] The Comprehensive History of Biotechnology: Origins, Key Areas, and ... — Early Biotechnology (Ancient Civilizations to Pre-Industrial Revolution) The history of biotechnology begins with the first agricultural societies that learned how to manipulate nature to enhance food production and improve quality of life. One of the earliest examples of biotechnology is fermentation, a process that was used by ancient civilizations to make bread, beer, and wine.
[59] PDF — advancements made by ancient civilisations. Biotechnology in ancient civilisations In roughly 6000 BC, the Sumerians and Babylonians harnessed biotechnology and mastered the art of fermenting yeast to brew beer.2 It was a practice rooted in observation and tradition, rather than scientific under standing. They harnessed the natural process
[66] History of Biotechnology: Check Brief History, Origin, Timeline! — NameContribution to History of BiotechnologyKarl ErkeyCoined the term "biotechnology" in 1919Gregor MendelProposed "Laws of Inheritance" and laid the foundation for geneticsLouis PasteurPioneered vaccination and made significant contributions to microbiologyJames Watson & Francis CrickUnveiled the Double Helix Model of DNA in 1953, revolutionizing geneticsCraig VenterSequenced the human genome, advancing our understanding of geneticsT.H. MorganDemonstrated the role of chromosomes in inheritance using fruit fliesRobert KochDiscovered bacterial colonies and contributed to the field of microbiologyAlexander FlemingDiscovered antibiotics, including penicillin, saving countless livesHargobind KhoranaSynthesized DNA in a test tube, a pivotal achievement in genetic engineeringIan WilmutSuccessfully cloned an adult animal, known as "Dolly the sheep"Wilhelm JohannsenCoined the term "gene" and introduced "genotype" and "phenotype"Robert BrownDiscovered the nucleus in cells, a key milestone in cell biologyFredrich MiescherIsolated nucleic acid (DNA) from white blood cells, paving the way for DNA researchHeinrich Wilhelm Gottfried Von Waldeyer-HartzCoined the term "chromosome"Edward JennerDeveloped the smallpox vaccine, a landmark in immunizationHugo de Vries, Erich Von Tschermak, Carl CorrensValidated Mendel's work on genetics in 1900
[68] Biotechnology History and Timeline - Biology Simple — Biotechnology Biotechnology The modern era of biotechnology brought about ethical concerns, particularly regarding genetically modified organisms (GMOs) and cloning. Future developments in biotechnology, such as CRISPR-Cas9 and synthetic biology, offer promising possibilities but require careful ethical considerations. Throughout history, there have been numerous key discoveries in the field of biotechnology that have revolutionized our understanding of living organisms and paved the way for advancements in medicine, agriculture, and industry. One of the key ethical implications of biotechnology in the modern era is the controversy surrounding genetically modified organisms (GMOs). Over time, key discoveries and advancements have revolutionized the field, leading to the modern era of biotechnology. Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
[89] The top biotech breakthroughs that defined 2023 — As we look back at 2023 it is clear that the year has been marked by steady progress and notable breackthroughts in the biotech industry. From advancements in Alzheimer’s disease treatments to new approaches in cancer therapy, artificial intelligence (AI) progression, and obesity management, this year has seen important steps forward in healthcare and medical research. Here is an overview of some of the key biotech developments that have shaped the biotech industry in 2023. The 2023 biotech breakthroughs in Alzheimer’s treatments, oncology, and obesity as well as other areas demonstrates the industry’s commitment to tackling some of the most challenging health issues. As we move into a new year, the biotech sector continues to stand at the forefront of scientific breakthroughs, poised to deliver solutions that could transform lives and shape the future of healthcare.
[93] Integrating computational biology and multiomics data for precision ... — Integrating computational biology and multiomics data for precision medicine in personalized cancer treatment - ScienceDirect Chapter 14 - Integrating computational biology and multiomics data for precision medicine in personalized cancer treatment In the pursuit of advancing personalized cancer treatment, this research explores the integration of computational biology methodologies with multiomics data analysis. Through the integration of computational biology and multiomics data, this research endeavors to propel the paradigm of precision medicine toward a more refined and individualized approach in the realm of cancer therapeutics. Copyright © 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Brawley, …, Sara R. For all open access content, the Creative Commons licensing terms apply.
[95] PDF — Integration of proteomics and genomics for personalized medicine. 2024; 8(4):220 Integration of proteomics and genomics for personalized medicine. This transformation is driven by the integration of genomics and proteomics, two powerful fields that offer complementary insights into the biological underpinnings of disease and health. The integration of proteomics and genomics is crucial for a comprehensive understanding of biological systems. By integrating genomic data with protein expression profiles, researchers can identify potential therapeutic targets and biomarkers for early diagnosis and disease progression monitoring. The integration of proteomics and genomics represents a powerful approach to advancing personalized medicine. By combining the static genomic blueprint with dynamic proteomic profiles, researchers and clinicians can gain a comprehensive understanding of disease mechanisms and patient-specific factors. Integration of proteomics and genomics for personalized medicine.
[98] Ethical Issues of Artificial Intelligence in Medicine and Healthcare — AI applications in healthcare have literally changed the medical field, including imaging and electronic medical records (EMR), laboratory diagnosis, treatment, augmenting the intelligence of the physicians, new drug discovery, providing preventive and precision medicine, biological extensive data analysis, speeding up processes, data storage and access for health organizations. It should be noted that the ethical dilemmas, privacy and data protection, informed consent, social gaps, medical consultation, empathy, and sympathy are various challenges that we face in using AI. Therefore, before integrating artificial intelligence with the healthcare system, practitioners and specialists should consider all four medical ethics principles, including autonomy, beneficence, nonmaleficence, and justice in all aspects of health care (2–6) (Fig. 1) (7, 8).
[99] Ethical Considerations in the Use of Artificial Intelligence and ... — By addressing privacy and data security concerns proactively and transparently, healthcare organizations can build trust with patients, mitigate ethical risks associated with AI and ML applications, and harness the full potential of these technologies to improve patient care and advance medical research, while safeguarding patient privacy and autonomy. By ensuring that healthcare providers and patients understand the rationale behind algorithmic recommendations and the limitations of AI-driven decision-making, healthcare organizations can promote the ethical and responsible use of AI and ML in health care, ultimately improving patient outcomes and advancing the delivery of personalized, evidence-based care . By addressing issues such as data privacy and security, algorithmic bias, transparency, clinical validation, and professional responsibility, healthcare stakeholders can navigate the ethical complexities surrounding AI and ML integration in health care, while safeguarding patient welfare and upholding the principles of beneficence, non-maleficence, autonomy, and justice.
[102] The potential of CRISPR-Cas9 for treating genetic disorders — CRISPR-Cas9-mediated genome editing has been performed in a wide range of human cell lines including human embryonic kidney cells (Mali et al., 2013) induced pluripotent stem cells (iPSCs) (Smith et al., 2014a), and most recently in early human embryos (Liang et al., 2015). CRISPR-Cas9 technology differs from ZFNs and TALENs as it is derived from a naturally occurring mechanism and is targeted by bp between the sgRNA and target DNA (Jinek et al., 2012). Digenome-seq is a recently developed method that sequences in vitro Cas9-digested genomes from a population of edited cells, allowing detection of rare off-target mutations (Kim et al., 2015) which would be useful for Cas9-mediated stem cell therapy.
[104] Applications and challenges of CRISPR-Cas gene-editing to disease ... — A variety of studies have applied CRISPR-Cas systems for effectively targeting different genes and have managed to prove the potential treatment ability for initiation or progression of lung cancer,64 breast cancer,65,66 and many other types of cancers.67–69 Meanwhile, the CRISPR-Cas system has been harnessed to serve as a powerful tool with the ability of unbiased screening of precision medicine including identification of new drug targets, biomarkers, and elucidation of mechanisms leading to drug resistance.70–72 In short, there are tremendous potential applications for CRISPR-Cas and their derivative systems (i.e. dCas9) due to the ability to accurately determine the underlying disease causes, genetic mutation variants, immunological regulatory factors, cell signaling mediators, and drug targets as well as drug molecules and therapeutics.
[105] Advances in CRISPR/Cas-based Gene Therapy in Human Genetic Diseases — Advances in CRISPR/Cas-based Gene Therapy in Human Genetic Diseases - PMC Advances in CRISPR/Cas-based Gene Therapy in Human Genetic Diseases Keywords: CRISPR/Cas, Gene editing, Gene therapy, Human disease, Genetic disease To date, three clinical trials aiming to treat patients with β-thalassemia and severe sickle cell disease by transfusion of CRIPSR/Cas9 edited CD34+ human HSCs (CTX001) have been initiated by CRISPR Therapeutics in 2018 and Allife Medical Science and Technology Co., Ltd in 2019 (Table 3). Similarly, CRISPR/Cas- induced NHEJ has been used to treat DMD in a DMD dog model after AAV-mediated systemic delivery of CRISPR gene editing components.
[107] CRISPR Gene Therapies: Current Challenges and a Promising Future — Arguably the greatest challenge to be overcome before the widespread clinical application of CRISPR-based gene editing is mitigating the risk of off-target effects—or unintended genetic alterations at sites other than the intended target.4 Researchers have made significant progress in improving the precision of CRISPR by developing more precise Cas9 variants and optimizing guide RNA designs. But the reliance on the introduction of a DSB can also cause significant safety issues, with CRISPR gene editing leading to cell death, or large base-deletions and chromosomal disorganization with the potential to cause malignant tumors.5 A key focus has been to develop CRISPR systems that do not introduce a DSB—systems such as base editing, prime editing, and the derivatives TWIN-PE and PASTE facilitate gene editing without a DSB, from single nucleotide changes to large-scale insertions of genetic material, with huge future potential for gene therapy.6
[127] Biotechnology: Introduction, Scope and Applications of Biotechnology — The applications of biotechnology includes plant tissue culture, production of transgenic in animal and plants, applications in medicine as tools and therapeutics, creation of new enzymes and their immobilization for industrial use, development of monoclonal antibodies and control of pollutions, etc. This includes plant tissue culture, production of transgenic in animal and plants, applications in medicine as tools and therapeutics, creation of new enzymes and their immobilization for industrial use, development of monoclonal antibodies and control of pollutions, etc. Within the field of red biotechnology, which deals with applications in human and animal medicine, there are various further distinctions that can be made: biopharmaceutical drug development, drug delivery cell and gene therapies, tissue engineering/regenerative medicine, pharmacogenomics (personalized medicine), system biology, and diagnosis using molecular medicine.
[129] An Introduction to Biotechnology - PMC - PubMed Central (PMC) — In this chapter the readers will understand the potential applications of biotechnology in several fields like production of medicines; diagnostics; therapeutics like monoclonal antibodies, stem cells, and gene therapy; agricultural biotechnology; pollution control ( bioremediation); industrial and marine biotechnology; and biomaterials, as well as the ethical and safety issues associated with some of the products. This fieldof biotechnology has many applications and is involved in production of recombinant pharmaceuticals, tissue engineering products, regenerative medicines such as stem cell and gene therapy, and many more biotechnology products for better human life (Fig. 1.6).
[130] Biotechnology and Its Applications: A Review - ResearchGate — This paper aimed at evaluating biotechnology with respect to its application. Major areas of applications identified in the literature are environment, medicine, agriculture, food processing and
[133] Enabling Genome Editing for Enhanced Agricultural Sustainability — It has since been established that the adoption of transgenic (or genetically modified, GM) crops has contributed to improving the sustainability of agricultural practices.
[134] (PDF) Transgenic Crops: Implications for Biodiversity and Sustainable ... — The potential for genetically modified (GM) crops to threaten biodiversity conservation and sustainable agriculture is substantial. Megadiverse countries and centers of origin and/or diversity of crop species are particularly vulnerable regions. The
[135] Environmental impacts of genetically modified plants: A review — Debates about the commercial introduction of genetically modified (GM) crops started soon after the development of the first transgenic organism (1970s) which led to the development of guidelines for use of recombinant DNA by the US (United States) National Institute of Health (NIH, 2013). Generally, risks to the environment could be summarized as (1) risks associated with biodiversity including ecosystem functions effects on soil, and non-target species; (2) risks associated with gene flow and genetic recombination; and (3) risks associated with their evolution i.e. development of resistance either in insect pests or in weeds and Bacillus thuringiensis (Bt) crops. Firstly, toxicity produced by chemicals used with GM crops, is a big challenge to the environment as well as to the inherited plants (De Schrijver et al., 2015).
[136] Executive Summary - Environmental Effects of Transgenic Plants - NCBI ... — Before transgenic plants can be grown outside the laboratory, approval must be obtained from the Animal and Plant Health Inspection Service (APHIS) of the United States Department of Agriculture (USDA). APHIS derives its authority for regulating transgenic plants from the Federal Plant Pest Act (FPPA) and the Federal Plant Quarantine Act (FPQA). As a participant in the U.S. Coordinated
[149] Climate-Resilient Crops: Plant Biotechnology and Breeding for ... — Climate-Resilient Crops: Plant Biotechnology and Breeding for Sustainable Agriculture | Wikifarmer Climate-Resilient Crops: Plant Biotechnology and Breeding for Sustainable Agriculture Climate-Resilient Crops: Plant Biotechnology and Breeding for Sustainable Agriculture Plant biotechnology plays a pivotal role in developing climate-resilient crops through advanced breeding techniques and the use of genetic resources. CRISPR/Cas-9 in Soybean and Cocoa: Gene editing has improved drought and salt tolerance by targeting genes like Drb2a and Drb2b, showcasing potential for wider application in climate-resilient crops. Breeding Methods: Farmers have benefited from breeding techniques like Selection by identifying and propagating plants with superior traits (e.g., drought tolerance), Hybridization by combining traits from diverse parent plants for improved stress tolerance and Mutation Breeding by inducing genetic variations to develop resilient crop varieties.
[150] Biotechnology and Climate Change | Home - USDA — Agricultural biotechnology can be an important tool for addressing the causes and consequences of climate change and for achieving important societal goals such as reduced poverty, improved global food security, and reduced environmental impacts from agriculture. That's why agricultural biotechnology is part of USDA's toolkit for a healthy planet and sustainable future. Causes and impacts
[151] Engineering crops of the future: CRISPR approaches to develop climate ... — With population increasing while agricultural land area decreases and crops experience constant threats from climate change, a vital route toward maintaining food security is the development of climate-resilient crops.
[171] Applications of Biotechnology in Environment - Earth Reminder — The significant benefits of environmental biotechnology are that it helps us to make our environment safer and cleaner for further use. Further, it helps the organisms and therefore; the engineers seek helpful ways for adapting to the changes in the environment and keep it clean.
[172] Biotechnology and the Environment: Benefits and Concerns — Benefits of Biotechnology for the Environment Reducing Greenhouse Gas Emissions. Agricultural biotechnology can play a crucial role in mitigating climate change by reducing greenhouse gas emissions. For instance, biotechnology can be used to develop cover crops that provide sustainable biofuels, reducing the reliance on fossil fuels and
[173] 10 Advantages and Benefits of Biotechnology - Environment Go! — The benefits of biotechnology have over time been figured out to be an essential factor in the conservation, protection, and sustainability of the environment. Biotechnology is a broad and ever-growing field that deals with the combination of biological and Technological concepts for the benefit of man.
[174] Biotechnology Positive Impacts - Biology Simple — Biotechnology has numerous positive impacts, such as reducing environmental pollution, saving lives, and increasing food production. These benefits include the bioproduction of sustainable chemicals, energy, and materials, the development of genetically modified crops for sustainable food production, the use of seawater bioprocesses to produce fuel and chemicals, and the advancement of
[175] Section 3.9: Biotechnology And The Environment - docmckee.com — Biotechnology is helping agriculture adapt to the impacts of climate change by developing crops that are more resilient to drought, heat, and salinity. These traits enable farmers to maintain productivity under challenging environmental conditions, reducing the need for land conversion and preserving ecosystems.
[176] Editorial: Ecological Consequences of Biodiversity and Biotechnology in ... — The ecological consequences of biomass production systems need to be evaluated at landscape scale (Bredemeier et al.), and biotechnological methods can be used with advantage to investigate the relationships between genetic diversity in tree plantations and an indicator for biodiversity (here arthropod abundance) as an ecosystem service (Zhang
[177] Turning promise into practice: Crop biotechnology for increasing ... — As climate change increasingly threatens agricultural production, expanding genetic diversity in crops is an important strategy for climate resilience in many agricultural contexts. In this Essay, we explore the potential of crop biotechnology to contribute to this diversification, especially in ind …
[179] The Pros and Cons of Biotechnology in Agriculture: A ... - GradesFixer — Biotechnology in agriculture is a hot topic these days, sparking debates among scientists, farmers, and consumers alike. As we delve into this intricate... read full [Essay Sample] for free ... This could lead to unintended consequences such as loss of biodiversity or development of "superweeds" resistant to herbicides.
[185] Unlocking Environmental Solutions: 5 Inspiring Real-World ... — Delta Remediation From oil spill cleanups to wastewater treatment, landfill remediation, and heavy metal cleanup, explore how microorganisms, fungi, and plants work together to create sustainable solutions. Case Study: Exxon Valdez Oil Spill (1989) In the Exxon Valdez oil spill, bioremediation techniques introduced oil-degrading bacteria for a responsible and sustainable cleanup, showcasing an eco-friendly approach to industrial accidents. Contact Delta Remediation Delta Remediation is at the forefront, offering rapid bioremediation techniques. Join us in our mission for a cleaner, healthier environment with Delta Remediation’s innovative bioremediation solutions. Delta Remediation Delta Remediation, an Alberta leader in bioremediation, uses natural bacteria to degrade hydrocarbons, turning contaminants into water and CO2. © 2023 Delta Remediation - Premier In-Situ & Ex-Situ Bioremediation Providers.
[186] A comprehensive review of sustainable bioremediation techniques: Eco ... — Bioremediation represents a cutting-edge and ecologically sustainable technology that utilizes biological microorganisms to decompose and neutralize pollutants (Ajona and Vasanthi, 2021).This technique plays a crucial role in removing environmental toxins, thereby restoring ecosystems to their natural state and preventing further contamination (Sardrood et al., 2013, Arregui et al., 2019
[187] Oil Biodegradation and Bioremediation: A Tale of the Two Worst Spills ... — The devastating environmental impacts of the Exxon Valdez spill in 1989 and its media notoriety made it a frequent comparison to the BP Deepwater Horizon spill in the popular press in 2010, even though the nature of the two spills and the environments impacted were vastly different. Fortunately, unlike higher organisms that are adversely impacted by oil spills, microorganisms are able to
[188] Microbes' role in environmental pollution and remediation: a bioeconomy ... — Moreover, focus has been given to the implementation of bioremediation as a novel approach to agro-industrial waste management, highlighting how it is possible to reduce environmental pollution while still obtaining value-added products with commercial value, meeting the goals of a circular bioeconomy. Currently, the scientific community supports the straight connection between biorefinery and bioremediation concepts to encourage circular bio/economy practices by enabling the production of value-added-products carried out by microbial pathways addressed to “zero waste”, in comparison to classical waste management strategies ,. Microbial biorefinery-based technologies could provide major breakthroughs in bio-based economies through the production of several market-based products such as biopolymers, biofuels, biochemicals, bio-additives, pigments, single-cell proteins, and single-cell oils, through “cascade” and/or “one-pot” fermentation approaches, according with the third type of bioeconomy proposed by Vivien et al.
[195] Bioremediation: an emerging and sustainable biotechnological method for ... — As water pollution continues to pose a critical threat, bioremediation stands out as an emerging and sustainable solution with the potential to restore polluted water ecosystems. Its eco-friendly nature, cost-effectiveness, and adaptability make it a valuable tool in the broader effort to address the complex challenges of water pollution and
[196] Section 3.9: Biotechnology And The Environment — At the same time, the deployment of biotechnological innovations must be approached cautiously, as unintended ecological consequences could disrupt ecosystems and create new problems. By leveraging the tools of life sciences, biotechnology has the potential to transform how we interact with and steward the natural world.
[197] From pollutants to products: Microbial cell factories driving ... — From pollutants to products: Microbial cell factories driving sustainable biomanufacturing and environmental conservation - ScienceDirect From pollutants to products: Microbial cell factories driving sustainable biomanufacturing and environmental conservation Through advancements in metabolic engineering, gene editing technologies, and synthetic biology, microbial cell factories are being optimized to enhance their efficiency in breaking down pollutants and producing renewable chemicals, such as biofuels, bioplastics, and specialty chemicals. Detailed case studies illustrate successful implementations, such as the conversion of lignocellulosic biomass, CO2, and industrial waste into high-value products, underscoring the practical impact of microbial cell factories in diverse sectors, including energy, materials, and chemicals. One promising approach involves utilizing microbial cell factories to convert pollutants into valuable products, transforming waste streams into resources through bioconversion processes.
[212] 6 Major Ethical Issues in Biotechnology and How to Address Them — 6 Major Ethical Issues in Biotechnology and How to Address Them - Nirdosh Jagota - Biotech Industry Leader and Innovator To address these concerns, it’s essential to establish international guidelines and ethical frameworks for human gene editing. Addressing these disparities is an ethical obligation and a way to ensure that biotechnology fulfills its potential to improve global health outcomes. Addressing Ethical Concerns in Biotechnology International Collaboration: Many ethical issues in biotechnology, such as dual-use research and genetic privacy, transcend national borders. From genetic privacy to dual-use research, each of these ethical issues requires careful consideration and responsible action. Addressing these ethical issues isn’t just a responsibility—it’s essential to realizing biotechnology’s full potential for the benefit of society as a whole.
[213] Ethical Issues of Biotechnology, Major Concerns and Analysis — UPSC Exam UPSC Exam UPSC Syllabus 2025 UPSC Syllabus 2025 UPSC Exam Pattern 2025 UPSC Previous Year Question Papers All About UPSC Exam All About UPSC Exam UPSC IES/ISS Syllabus and Exam Pattern UPSC IFS Exam UPSC IFS Exam UPSC CMS Exam UPSC CMS Exam UPSC CMS Syllabus and Exam Pattern MPSC Syllabus and Exam Pattern CGPSC Syllabus and Exam Pattern UKPSC Syllabus and Exam Pattern JKPSC Syllabus and Exam Pattern Ethical Issues of Biotechnology UPSC Ethical Issues of Biotechnology UPSC The manipulation of genetic codes, cloning, gene therapy, and issues related to privacy and intellectual property present significant ethical concerns. Ethical issues in biotechnology are categorized into socio-economic, cultural, legal, environmental, and religious concerns. UPSC Exam Pattern 2025
[216] Bioethics and biotechnology - PMC - PubMed Central (PMC) — The ethical assessment of new technologies, including biotechnology, requires a different approach to ethics. Changes are necessary because new technology can have a more profound impact on the world; because of limitations with a rights-based approach to ethics; because of the importance and difficulty of predicting consequences; and because biotechnology now manipulates humans themselves. The human capacity for good or evil, whether intended or unintended, impacts how people view the ethics of technology. Biotechnology requires answers to these questions to address ethical concerns about non-human species and nature as a whole. Developments in biotechnology point to serious limitations with a rights-based approach to ethics. No area of biotechnology more clearly brings to focus the need for careful ethical reflection than its potential to impact human nature.
[217] Ethics of Gene Therapy: Balancing Progress and Morality — Adhering to these principles helps navigate the complex ethical landscape of gene manipulation and therapy, facilitating progress while upholding moral values and ensuring responsible advancements in genetic treatment. The ethical implications surrounding gene therapy and genetic manipulation require careful consideration to strike a balance between the potential for progress and the preservation of moral standards. This section aims to critically evaluate the morality of gene manipulation by considering societal values, ethical principles, and the potential consequences of genetic editing. The public’s perspective on the moral and ethical considerations surrounding genetic manipulation and treatment is a critical aspect to consider as we navigate the advancements in gene editing and therapy.
[218] Ethical Considerations in Genetic Engineering and Gene Therapy — Ethical Considerations in Genetic Engineering and Gene Therapy • Philosophy Institute Ethical Considerations in Genetic Engineering and Gene Therapy From the morality of genetic manipulation to concerns about playing with the very fabric of life, these are not just scientific issues, but deeply philosophical ones. The morality of human genetic manipulation 🔗 Using genetic engineering for the greater good: If genetic engineering can be applied in a way that benefits all of humanity without exploiting individuals, it may be considered morally acceptable under Kantian ethics. Risks of devaluing human life: However, if genetic engineering leads to a society where individuals are valued only for their genetic traits, it would run counter to the Kantian principle of respecting the inherent worth of every person. Human Genetic Engineering
[221] What are the Ethical Concerns of Genome Editing? — Most of the ethical discussions related to genome editing center around human germline because editing changes made in the germline would be passed down to future generations. Overview The debate about genome editing is not a new one but has regained attention following the discovery that CRISPR has the potential to make such editing more accurate and even "easy" in comparison to older technologies. As of 2014, there were about 40 countries that discouraged or banned research on germline editing, including 15 nations in Western Europe, because of ethical and safety concerns.3 There is also an international effort led by the US, UK, and China to harmonize regulation of the application of genome editing technologies. Researchers and ethicists who have written and spoken about genome editing, such as those present at the International Summit on Human Gene Editing, generally agree that until germline genome editing is deemed safe through research, it should not be used for clinical reproductive purposes; the risk cannot be justified by the potential benefit. Researchers and bioethicists also worry about the possibility of obtaining truly informed consent from prospective parents as long as the risks of germline therapy are unknown.10 Justice and Equity As with many new technologies, there is concern that genome editing will only be accessible to the wealthy and will increase existing disparities in access to health care and other interventions.
[224] The Biological Impact Assessing Effectiveness and Risks — Assessing the effectiveness of biotechnological interventions in agriculture requires a nuanced understanding of their ecological implications. While GMOs offer undeniable benefits in terms of crop productivity and resource efficiency, their long-term effects on biodiversity and ecosystem functioning remain uncertain.
[225] Section 3.9: Biotechnology And The Environment — As humanity faces unprecedented environmental challenges, biotechnology offers innovative solutions for pollution remediation, climate change mitigation, and biodiversity preservation. Biotechnology offers powerful tools to address climate change by reducing greenhouse gas emissions, capturing carbon, and developing sustainable alternatives to fossil fuels. Biotechnological interventions, such as pest-resistant crops or gene drives, can have unintended effects on non-target species. Addressing the ethical and environmental trade-offs of biotechnology requires robust frameworks for risk assessment, public dialogue, and adaptive governance. Environmental challenges are global in nature, and the use of biotechnology to address these challenges requires international cooperation. Their analysis underscores the need for informed and balanced perspectives to guide the responsible use of biotechnology in addressing environmental challenges.
[249] Addressing Regulatory Issues in Biotechnology for Compliance — Biotechnology regulation encompasses a framework of laws and guidelines that govern biotechnological practices, ensuring safety, efficacy, and ethical compliance. Regulatory bodies face the task of developing adaptive frameworks that respond effectively to novel biotechnologies while considering public health, safety, and ethical standards. Their regulations and guidelines shape research, product development, and market entry, impacting the overall landscape of regulatory issues in biotechnology. The interplay of compliance and enforcement mechanisms ensures that regulatory issues in biotechnology are addressed, promoting public confidence in biotechnological advancements. Navigating the regulatory approval process in biotechnology involves a series of structured steps designed to assess safety, efficacy, and compliance with relevant laws before products can reach the market.
[255] Biotech Trends in 2023: Pioneering Discoveries & Innovations — Home/Biotechnology_/_Biotech Trends in 2023: Pioneering Discoveries and Innovations From cutting-edge gene editing technologies to AI-driven drug discovery, this article provides a comprehensive overview of the emerging biotech trends in 2023. Gene editing, cell and gene therapies, AI-driven drug discovery, synthetic biology, and digital health solutions are among the pioneering trends that will shape the future of biotechnology. I have read and agree to the Terms and Conditions and Privacy Policy AI Artificial Intelligence Augmented reality Biotechnology blockchain Cloud Cloud computing Crypto Cryptocurrencies cybercrime Cybersecurity Decentralized Ethical hacking Industrial Internet iot Machine learning medical I have read and agree to the Terms and Conditions and Privacy Policy I have read and agree to the Terms and Conditions and Privacy Policy
[257] 5 biotech trends to watch in 2023 - Big Think — Learn More → Follow Us View our Youtube channelView our Facebook pageView our Instagram feedView our Twitter (X) feedView our LinkedIn account Search for: Open the Main Navigation Search Return to homepage For Business Subscribe Health — January 12, 2023 5 biotech trends to watch in 2023 From synthetic biology to xenotransplantation, biotech will continue to march forward in 2023, in part powered by data and AI. As the Deputy Director of Communications for Leaps by Bayer, I surveyed a brain trust of scientists, investors, and CEOs to learn which areas of biotech they are most eagerly watching this year. Cell and gene therapies Cell and gene therapies encompass a wide range of approaches that attempt to treat disease at the cellular and genetic level. In gene therapy, genetic material is delivered into patients’ bodies with the objective of replacing or correcting faulty DNA. Researchers are concentrating on making pig hearts, lungs, and kidneys safe by genetically engineering their DNA to be accepted by human immune systems.
[258] The biggest biotech trends that will shape 2023 — We have collected seven major biotech trends that industry experts are keeping an eye on over the next 12 months. 2023 has already launched with announcements of big pharma acquisitions and the approval of Eisai and Biogen’s Alzheimer’s drug lecanemab by the U.S. Food and Drug Administration (FDA). Now it’s time to reflect on some of the biggest biotech trends that analysts and investors see developing over 2023. The coming year will reveal how the industry can adapt to the IRA, and what decisions are taken by big and small drugmakers alike.
[260] 5 Biotechnology Trends and Innovations to Watch in 2023 — 5 Biotechnology Trends and Innovations to Watch in 2023 - MassChallenge MassChallenge Community Close Community Open Community Founders Experts Partners Investors Join Founders Experts Partners Investors Join Industry Close Industry Open Industry Climate Dual Use FinTech Healthcare Sustainable Food Systems Climate Dual Use FinTech Healthcare Sustainable Food Systems Accelerators Close Accelerators Open Accelerators Early Stage Founder-focused & industry agnostic Challenge Programs Industry-specific for mid-to-late stage startups Additional Programs A variety of mentorship & industry focuses for all stages Bridge to MC Driving innovation & startup ecosystem development Partnerships Close Partnerships Open Partnerships Corporate Innovation Community Partners Corporate Innovation Community Partners Hubs Close Hubs Open Hubs United States Israel Mexico Switzerland United Kingdom United States Israel Mexico Switzerland United Kingdom About Close About Open About About us 2023 Impact Report Featured Startups Innovation Blog Case Studies Upcoming Events News Diversity, Equity, and Inclusion Ways to Support About us 2023 Impact Report Featured Startups Innovation Blog Case Studies Upcoming Events News Diversity, Equity, and Inclusion Ways to Support Community Close Community Open Community Founders Experts Partners Investors Join Founders Experts Partners Investors Join Industry Close Industry Open Industry Climate Dual Use FinTech Healthcare Sustainable Food Systems Climate Dual Use FinTech Healthcare Sustainable Food Systems Accelerators Close Accelerators Open Accelerators Early Stage Founder-focused & industry agnostic Challenge Programs Industry-specific for mid-to-late stage startups Additional Programs A variety of mentorship & industry focuses for all stages Bridge to MC Driving innovation & startup ecosystem development Partnerships Close Partnerships Open Partnerships Corporate Innovation Community Partners Corporate Innovation Community Partners Hubs Close Hubs Open Hubs United States Israel Mexico Switzerland United Kingdom United States Israel Mexico Switzerland United Kingdom About Close About Open About About us 2023 Impact Report Featured Startups Innovation Blog Case Studies Upcoming Events News Diversity, Equity, and Inclusion Ways to Support About us 2023 Impact Report Featured Startups Innovation Blog Case Studies Upcoming Events News Diversity, Equity, and Inclusion Ways to Support Give Give Login Apply Innovation Blog 5 Biotechnology Trends and Innovations to Watch in 2023 Published on: January 23, 2023 Author: masschallenge Biotech is disrupting how we approach health, medicine, and agriculture. The global biotechnology market is currently valued at 752.8 Billion — and growing. Understanding these trends in biotechnology can help companies capitalize on the explosive growth potential of the industry. This article will cover the trends in biotech that are set to change the world.
[261] The top biotech breakthroughs that defined 2023 — As we look back at 2023 it is clear that the year has been marked by steady progress and notable breackthroughts in the biotech industry. From advancements in Alzheimer’s disease treatments to new approaches in cancer therapy, artificial intelligence (AI) progression, and obesity management, this year has seen important steps forward in healthcare and medical research. Here is an overview of some of the key biotech developments that have shaped the biotech industry in 2023. The 2023 biotech breakthroughs in Alzheimer’s treatments, oncology, and obesity as well as other areas demonstrates the industry’s commitment to tackling some of the most challenging health issues. As we move into a new year, the biotech sector continues to stand at the forefront of scientific breakthroughs, poised to deliver solutions that could transform lives and shape the future of healthcare.
[262] Understanding Biotechnology Regulations: A Comprehensive Overview — The interplay between biotech innovations and legal oversight influences various sectors, from agriculture to medicine. As society increasingly relies on genetic technologies, the importance of robust biotechnology regulations cannot be overstated; they safeguard not only innovation but also public health and ecological integrity.
[264] Biotechnology in 2024: How to Navigate the Shifting Landscape - DocXellent — Adapt to Emerging Biotech Industry Trends. The biotechnology landscape in 2024 is marked by rapid advancements, ethical considerations, and a regulatory landscape in flux. Companies that proactively navigate these shifts will not only ensure regulatory compliance but also position themselves as leaders in shaping the future of biotechnology.
[287] Artificial Intelligence in Drug Discovery: Current Breakthroughs — AI is transforming drug discovery by enhancing target identification, optimizing lead compounds, and improving predictive modeling for safety and efficacy. AI-driven models analyze vast datasets, predict molecular interactions, and optimize drug candidates with unprecedented speed. A study in Nature Communications demonstrated how AI-driven network-based approaches identified new therapeutic targets for Alzheimer’s disease by analyzing protein-protein interaction networks and gene co-expression data. Machine learning models trained on historical screening data identify chemical structures likely to bind to a target, allowing researchers to prioritize promising candidates. Transfer learning enhances hit-to-lead optimization by leveraging knowledge from existing drug discovery datasets to improve predictions for new compounds. Traditionally, these models relied on compartmental equations and empirical data, but AI-driven approaches enhance predictive accuracy by integrating vast datasets from preclinical and clinical studies.
[288] The Role of AI in Drug Discovery: Challenges, Opportunities, and ... — Artificial intelligence (AI) has the potential to revolutionize the drug discovery process, offering improved efficiency, accuracy, and speed. AI-based approaches, on the other hand, have the ability to improve the efficiency and accuracy of drug discovery processes and can lead to the development of more effective medications. By combining the predictive power of AI with the expertise and experience of human researchers , it is possible to optimize the drug discovery process and accelerate the development of new medications . Recent developments in AI, including the use of data augmentation, explainable AI, and the integration of AI with traditional experimental methods, offer promising strategies for overcoming the challenges and limitations of AI in the context of drug discovery.
[289] Integrating artificial intelligence in drug discovery and early drug ... — There are several limitations, specific to drug discovery and development in cancer, that can be summarized in the following concepts: (1) High Costs and Long Timelines: 10–15 years for a drug candidate to receive regulatory approval ; (2) Low Success Rates: approximately 90% of candidates that enter early clinical trials do not reach the market ; and (3) Complex Disease Biology: cancer involves complex, interconnected biological pathways that are difficult to target effectively with classical methods. As the main reasons for failures in drug development are insufficient efficacy and safety levels, methods based on AI could help mitigate challenges in the analysis of multiomics data by improving target identification and predicting druggability, which enhances the overall drug discovery process. An example of the integration of biological data for drug identification is PaccMann, an AI-driven framework designed to predict cancer cell sensitivity to compounds by integrating molecular structures, gene expression profiles, and protein interaction data.
[290] How successful are AI-discovered drugs in clinical trials? A first ... — How successful are AI-discovered drugs in clinical trials? How successful are AI-discovered drugs in clinical trials? open access We conducted a first analysis of the clinical pipelines of AI-native Biotech companies. In Phase I trials, AI-discovered molecules are substantially more successful than historic industry averages. Our analysis provides an early glimpse of the exciting clinical potential of AI-discovered molecules. In Phase I we find AI-discovered molecules have an 80–90% success rate, substantially higher than historic industry averages. Our findings highlight early signs of the clinical potential of AI-discovered molecules. Previous article in issue Next article in issue AI drug discovery AI-discovered drug AI drug in clinical trials No articles found. For all open access content, the relevant licensing terms apply.
[292] Machine learning models for drug-target interactions: current knowledge ... — Modeling approaches in drug-target interaction prediction. Machine learning and deep learning models in drug discovery. Machine-learning and deep-learning techniques using ligand-based and target-based approaches have been used to predict binding affinities, thereby saving time and cost in drug discovery efforts. In this review, we discuss about machine-learning and deep-learning models used in virtual screening to improve drug–target interaction (DTI) prediction. In the drug discovery pipeline, machine learning strategies have been used for small-molecular drug design as in virtual screening and de novo drug design (Fig. 2). We provide a brief overview of the ligand-based and target-based approaches used in virtual screening for identifying hits and leads in small-molecule drug discovery. Machine learning for drug-target interaction prediction Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling
[293] Comprehensive Review of Drug-Drug Interaction Prediction Based on ... — Detecting drug-drug interactions (DDIs) is an essential step in drug development and drug administration. Given the shortcomings of current experimental methods, the machine learning (ML) approach has become a reliable alternative, attracting extensive attention from the academic and industrial fields. With the rapid development of computational science and the growing popularity of cross
[294] On the road to explainable AI in drug-drug interactions prediction: A ... — Keywords: Explainable artificial intelligence, Drug-drug interaction, Machine learning, Deep learning, Chemical structures, Natural language processing Highlights • A systematic review on applications of explainable AI in drug-drug interaction prediction. • Review is conducted on a comprehensive set of 94 papers from five prestigious databases.